What is the Novartis patient Assistance Foundation?
The Novartis Patient Assistance Foundation, Inc. (NPAF) is committed to providing access to Novartis medications for those most in need. If you are experiencing financial hardship and have limited or no prescription coverage, then you may be eligible to receive Novartis medications for free.
What is a patient support service?
What are Patient Support Services? Specialized teams of medical professionals work together to provide the most comprehensive medical and mental health support to patients. Our aim is to provide health care that is personalized to each patient’s needs.
What can you do if you can’t afford your medication?
If you need help paying for your medications and healthcare costs, visit www.needymeds.org or call our toll-free helpline at 800-503-6897. Supported by a contribution from Pfizer, Inc. Patient: Simply present this card to a participating pharmacy to receive a discount on your prescription.
What does patient assistance do for Novartis patients?
Novartis Patient Assistance is a resource that helps connect patients to their Novartis medications and potential support.
Why do I need a Novartis co pay card?
At Novartis Pharmaceuticals Corporation, we know that access to your medication is important. That’s why we created a prescription co-pay savings program that’s simple to use and can help eligible patients with out-of-pocket costs. It’s easy to find out if you’re eligible and to activate your co-pay card.
How to contact Novartis Oncology for reimbursement?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-877-577-7756. Encourage your patients to find out if they are eligible to enroll in the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756.
How much does it cost to get a Novartis prescription?
Eligible patients pay no more than USD 30 for a 30-day prescription (USD 1 per day) through retail or mail order for the vast majority of our branded and biosimilar products, including our cancer portfolio.